| Name | Title | Contact Details |
|---|---|---|
Kelly Lewis |
Chief Operating Officer | Profile |
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.
Praestan Health is a new health technology company that is building a precision-guided suite of health and wellbeing applications to support practitioners and individuals in efficient, effective, and sustainable health behavior change.
Jones Regional Medical Center is a Anamosa, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lumetra is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.